Matinas BioPharma Holdings, Inc. (MTNB)

MTNB Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4.22	4.79	6.83	21.03	12.43	22.17
Short-Term Investments	10.1	8.97	21.93	28.59	46.25	5.6
Cash & Short-Term Investments	14.31	13.76	28.76	49.62	58.68	27.78
Cash Growth	-36.42%	-52.17%	-42.04%	-15.43%	111.27%	123.15%
Prepaid Expenses	0.92	1.74	5.72	1.32	2.74	1.9
Restricted Cash	-	-	-	-	0.14	0.25
Other Current Assets	0.05	0.05	0.05	0.05	-	-
Total Current Assets	15.29	15.54	34.53	50.99	61.55	29.92
Property, Plant & Equipment	4.53	5.01	5.73	5.78	4.86	5.63
Goodwill	1.34	1.34	1.34	1.34	1.34	1.34
Long-Term Deferred Charges	3.02	3.02	3.02	3.02	3.02	3.02
Other Long-Term Assets	0.2	0.2	0.2	0.2	0.2	0.34
Total Assets	24.37	25.1	44.82	61.33	70.97	40.24
Accounts Payable	0.24	0.51	0.62	0.94	0.35	0.68
Accrued Expenses	1.44	1.45	2.29	1.92	2.15	1.84
Current Portion of Leases	0.71	0.66	0.57	0.56	0.42	0.48
Current Unearned Revenue	-	-	0.72	0.03	0.07	0.1
Other Current Liabilities	-	-	0.09	0.9	0.58	-
Total Current Liabilities	2.39	2.62	4.29	4.35	3.57	3.1
Long-Term Leases	2.53	2.9	3.56	4.14	3.33	3.75
Long-Term Deferred Tax Liabilities	0.34	0.34	0.34	0.34	0.34	0.34
Total Liabilities	5.26	5.86	8.18	8.83	7.24	7.19
Common Stock	0.03	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	206.25	195.02	190.07	184.25	167.19	113.43
Retained Earnings	-187.12	-175.57	-152.63	-131.63	-107.51	-84.38
Comprehensive Income & Other	-0.05	-0.22	-0.82	-0.15	0.23	-0
Total Common Equity	19.1	19.25	36.64	52.49	59.93	29.07
Shareholders' Equity	19.1	19.25	36.64	52.49	63.73	33.05
Total Liabilities & Equity	24.37	25.1	44.82	61.33	70.97	40.24
Total Debt	3.24	3.56	4.12	4.7	3.75	4.23
Net Cash (Debt)	11.07	10.2	24.64	44.92	54.93	23.55
Net Cash Growth	-40.66%	-58.60%	-45.15%	-18.22%	133.28%	95.31%
Net Cash Per Share	2.46	2.35	5.68	10.69	13.95	8.11
Filing Date Shares Outstanding	5.02	4.35	4.35	4.34	4.09	3.93
Total Common Shares Outstanding	5.02	4.35	4.35	4.33	4	3.26
Working Capital	12.89	12.92	30.25	46.65	57.99	26.83
Book Value Per Share	3.81	4.43	8.43	12.14	14.97	8.91
Tangible Book Value	17.77	17.91	35.3	51.16	58.6	27.73
Tangible Book Value Per Share	3.54	4.12	8.12	11.83	14.64	8.50
Machinery	2.46	2.46	2.31	1.64	1.44	1.44
Leasehold Improvements	1.16	1.16	1.16	0.94	0.88	0.88

Source: S&P Capital IQ. Standard template. Financial Sources.